Related Experiment Video

Updated: Mar 15, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.8K

Cardiovascular Disease, Statins, and HIV

Allison Ross Eckard1, Eric G Meissner1, Inderjit Singh1

  • 1Medical University of South Carolina, Charleston.

The Journal of Infectious Diseases
|September 15, 2016
PubMed

Insights

Human immunodeficiency virus (HIV) infection causes chronic inflammation, increasing comorbidity risk even with treatment. Statins may mitigate this risk through their immunomodulatory effects in HIV patients.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Cardiology

Background:

  • HIV infection leads to immune dysfunction, chronic inflammation, and heightened immune activation.
  • This persistent inflammation increases the risk of serious non-AIDS-defining comorbidities, including cardiovascular disease, even with effective antiretroviral therapy.
  • Statins possess significant immunomodulatory properties.

Purpose of the Study:

  • To review the mechanisms of increased inflammation in HIV infection.
  • To examine the contribution of this inflammation to cardiovascular disease risk in HIV patients.
  • To explore the potential benefits of statins in managing comorbidities in this population.

Main Methods:

  • Literature review focusing on HIV pathogenesis, inflammation, and cardiovascular risk.
  • Review of studies on the immunomodulatory effects of statins.
  • Analysis of how statins may impact comorbidities in HIV-infected individuals.

Main Results:

  • Chronic HIV infection is characterized by persistent immune activation and inflammation.
  • Inflammation is a key driver of cardiovascular disease and other comorbidities in HIV patients.
  • Statins demonstrate broad immunomodulatory effects that could reduce inflammation and associated risks.

Conclusions:

  • Understanding HIV-associated inflammation is crucial for managing comorbidities.
  • Statins show promise in attenuating cardiovascular disease and other non-AIDS-defining comorbidities in HIV patients.
  • Further research into statin use in HIV management is warranted.

Keywords:
HIVcardiovascular diseasehydroxy-3-methylglutaryl coenzyme A reductase inhibitorsimmune activationinflammationstatins

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K
Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

3.0K

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
558
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
794
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.5K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.5K